Lexaria Bioscience

LEXX

Lexaria Bioscience is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard C. Christopher, with a market cap of $13.4M.

Market cap

$13.39M-32.9%

We’re still putting together Lexaria Bioscience’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Earnings

Q1 2026 report

April 13, 2026

Revenue$20.0KMiss by $30.0K EPS-$0.06Beat by $0.04

Read the full report

Next report

Jul 13, 2026 (In 3 weeks)

Revenue estimate$50.0K

EPS estimate-$0.06

Profile

CountryCanada

Listed2006

Employees3.0

CEORichard C. Christopher

SectorHealthcare

IndustryBiotechnology

Websitelexariabioscience.com

FilingsSEC EDGAR